Xia Qiu

720 total citations
26 papers, 565 citations indexed

About

Xia Qiu is a scholar working on Molecular Biology, Cancer Research and Immunology. According to data from OpenAlex, Xia Qiu has authored 26 papers receiving a total of 565 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 8 papers in Cancer Research and 7 papers in Immunology. Recurrent topics in Xia Qiu's work include Immunotherapy and Immune Responses (6 papers), Cancer-related molecular mechanisms research (5 papers) and Peptidase Inhibition and Analysis (4 papers). Xia Qiu is often cited by papers focused on Immunotherapy and Immune Responses (6 papers), Cancer-related molecular mechanisms research (5 papers) and Peptidase Inhibition and Analysis (4 papers). Xia Qiu collaborates with scholars based in China, Hong Kong and United States. Xia Qiu's co-authors include Tian Tian, Ran Qiu, Xianghui Yu, Haihong Zhang, Chenlu Liu, Tian Tian, Hui Wu, Ping Xu, Fang-Fang Zhang and Fei Geng and has published in prestigious journals such as Endocrinology, Vaccine and BMC Genomics.

In The Last Decade

Xia Qiu

24 papers receiving 565 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xia Qiu China 16 321 176 158 134 71 26 565
Sunil Tomar United States 12 326 1.0× 162 0.9× 124 0.8× 206 1.5× 9 0.1× 21 752
Eva M. Verdugo‐Sivianes Spain 12 258 0.8× 90 0.5× 146 0.9× 25 0.2× 57 0.8× 24 440
Youji Feng China 12 350 1.1× 129 0.7× 187 1.2× 57 0.4× 10 0.1× 33 582
Björn Kruspig Sweden 10 212 0.7× 117 0.7× 79 0.5× 62 0.5× 9 0.1× 13 386
Srujana Cherukuri United States 10 247 0.8× 83 0.5× 56 0.4× 60 0.4× 170 2.4× 12 655
Andrew J. Mhyre United States 11 238 0.7× 31 0.2× 94 0.6× 107 0.8× 13 0.2× 19 543
Xavier Gauthereau France 11 253 0.8× 65 0.4× 140 0.9× 106 0.8× 9 0.1× 16 469
Weiyi Xu China 15 486 1.5× 351 2.0× 54 0.3× 87 0.6× 24 0.3× 30 723
Peili Zhang China 14 378 1.2× 166 0.9× 30 0.2× 31 0.2× 83 1.2× 24 560
Jiawen Wang China 9 224 0.7× 52 0.3× 126 0.8× 195 1.5× 17 0.2× 15 548

Countries citing papers authored by Xia Qiu

Since Specialization
Citations

This map shows the geographic impact of Xia Qiu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xia Qiu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xia Qiu more than expected).

Fields of papers citing papers by Xia Qiu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xia Qiu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xia Qiu. The network helps show where Xia Qiu may publish in the future.

Co-authorship network of co-authors of Xia Qiu

This figure shows the co-authorship network connecting the top 25 collaborators of Xia Qiu. A scholar is included among the top collaborators of Xia Qiu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xia Qiu. Xia Qiu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Qiu, Xia, et al.. (2025). Proteomics-based investigation of the protective effect and mechanism of Agari-5 in rats with myocardial infarction. World Journal of Cardiology. 17(12). 112062–112062.
2.
Lei, Yupeng, Xia Qiu, & Ruixi Zhou. (2024). Construction and evaluation of neonatal respiratory failure risk prediction model for neonatal respiratory distress syndrome. BMC Pulmonary Medicine. 24(1). 8–8. 3 indexed citations
3.
Qiu, Xia, et al.. (2024). Mycophenolate mofetil after tacrolimus for refractory clinically amyopathic dermatomyositis: a case report. Frontiers in Pharmacology. 15. 1472667–1472667. 1 indexed citations
4.
Li, Rui, Wan Wang, Xia Qiu, et al.. (2023). Periostin promotes extensive neovascularization in placenta accreta spectrum disorders via Notch signaling. The Journal of Maternal-Fetal & Neonatal Medicine. 36(2). 2264447–2264447. 2 indexed citations
5.
Qiu, Xia, et al.. (2019). <p>LncRNA LINC00668 promotes the progression of breast cancer by inhibiting apoptosis and accelerating cell cycle</p>. OncoTargets and Therapy. Volume 12. 5615–5625. 20 indexed citations
6.
Wang, Xun, Yi Tang, Hui Xia, et al.. (2018). Transcriptomic insights into citrus segment membrane’s cell wall components relating to fruit sensory texture. BMC Genomics. 19(1). 280–280. 23 indexed citations
7.
Li, Zhaoming, Ran Qiu, Xia Qiu, & Tian Tian. (2018). EYA4 Promotes Cell Proliferation Through Downregulation of p27Kip1 in Glioma. Cellular Physiology and Biochemistry. 49(5). 1856–1869. 13 indexed citations
8.
Qiu, Xia, Fei Geng, Fang-Fang Zhang, et al.. (2016). Cyclophosphamide enhances anti-tumor effects of a fibroblast activation protein α-based DNA vaccine in tumor-bearing mice with murine breast carcinoma. Immunopharmacology and Immunotoxicology. 39(1). 37–44. 28 indexed citations
9.
Zhang, Haihong, Chenlu Liu, Fang-Fang Zhang, et al.. (2016). MUC1 and survivin combination tumor gene vaccine generates specific immune responses and anti-tumor effects in a murine melanoma model. Vaccine. 34(24). 2648–2655. 24 indexed citations
10.
11.
12.
Tian, Tian, et al.. (2016). MicroRNA-101 reverses temozolomide resistance by inhibition of GSK3β in glioblastoma. Oncotarget. 7(48). 79584–79595. 45 indexed citations
13.
Qiu, Xia, Fang-Fang Zhang, Fei Geng, et al.. (2016). Improvement of anti-tumor immunity of fibroblast activation protein α based vaccines by combination with cyclophosphamide in a murine model of breast cancer. Cellular Immunology. 310. 89–98. 27 indexed citations
14.
Qiu, Xia, et al.. (2016). Overexpression of FZD7 promotes glioma cell proliferation by upregulating TAZ. Oncotarget. 7(52). 85987–85999. 32 indexed citations
15.
Wu, Hui, Haihong Zhang, Yue Hu, et al.. (2014). Sphere Formation Assay is not an Effective Method for Cancer Stem Cell Derivation and Characterization from the Caco-2 Colorectal Cell Line. Current Stem Cell Research & Therapy. 9(2). 82–88. 6 indexed citations
16.
Wang, Yuqian, Haihong Zhang, Hui Wu, et al.. (2013). Enhancement of survivin-specific anti-tumor immunity by adenovirus prime protein-boost immunity strategy with DDA/MPL adjuvant in a murine melanoma model. International Immunopharmacology. 17(1). 9–17. 18 indexed citations
17.
Wang, Yuqian, Chenlu Liu, Xia Qiu, et al.. (2013). Antitumor effect of adenoviral vector prime protein boost immunity targeting the MUC1 VNTRs. Oncology Reports. 31(3). 1437–1444. 5 indexed citations
18.
Wu, Hui, Haihong Zhang, Peng Wang, et al.. (2013). Short‐Form CDYLb but not long‐form CDYLa functions cooperatively with histone methyltransferase G9a in hepatocellular carcinomas. Genes Chromosomes and Cancer. 52(7). 644–655. 14 indexed citations
19.
Zhang, Haihong, Yuqian Wang, Chenlu Liu, et al.. (2012). DNA and adenovirus tumor vaccine expressing truncated survivin generates specific immune responses and anti-tumor effects in a murine melanoma model. Cancer Immunology Immunotherapy. 61(10). 1857–1867. 25 indexed citations
20.
Wang, Yuqian, Haihong Zhang, Chenlu Liu, et al.. (2012). Correlation Between Auto-antibodies to Survivin and MUC1 Variable Number Tandem Repeats in Colorectal Cancer. Asian Pacific Journal of Cancer Prevention. 13(11). 5557–5562. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sunil Tomar Breakdown of academic impact, for papers by Eva M. Verdugo‐Sivianes Breakdown of academic impact, for papers by Youji Feng Breakdown of academic impact, for papers by Björn Kruspig Breakdown of academic impact, for papers by Srujana Cherukuri Breakdown of academic impact, for papers by Andrew J. Mhyre Breakdown of academic impact, for papers by Xavier Gauthereau Breakdown of academic impact, for papers by Weiyi Xu Breakdown of academic impact, for papers by Peili Zhang Breakdown of academic impact, for papers by Jiawen Wang
Rankless by CCL
2026